PARIS (AFP) – Real Madrid thrashed Shakhtar Donetsk 5-0 in the Champions League on Tuesday (Oct 19) as Karim Benzema scored on the eve of his trial in France on charges of complicity in blackmail. A first-half own goal from Serhiy Kryvtsov put Real on their way before Vinicius Junior scored two superb goals before... » read more
TOKYO, Sep 20, 2021 – (JCN Newswire via SEAPRWire.com) – HRC (Honda Racing Corporation) contract rider and Honda factory team(1) (Repsol Honda Team) rider Toni Bou has won the 2021 FIM(2) Trial World Championship. He has clinched his 15th consecutive title by winning the final round in Portugal, held on September 18. Toni Bou (Portuguese... » read more
TOKYO, Sep 15, 2021 – (JCN Newswire via SEAPRWire.com) – Honda announced that Honda Racing Corporation (HRC) contract rider Takahisa Fujinami (Repsol Honda Team), the first Japanese rider to win the FIM* Trial World Championship in 2004, will be retiring from the championship at the end of this season. Honda is truly grateful for all... » read more
LONDON, Aug 3, 2021 – (ACN Newswire via SEAPRWire.com) – The ClinTex (CTi) tokenized platform (clintex.io) will be the first of its kind to utilize blockchain-based clinical data analytics to address the main causes of clinical trial inefficiency, helping to drive down the cost of new medicines and expediting their delivery to patients. ClinTex (CTi)... » read more
ADELAIDE, AUS, Jun 4, 2021 – (ACN Newswire via SEAPRWire.com) – The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient Avance Clinical announced the results of their Australian Clinical Trials Knowledge Survey with Endpoints News as part of their presence at BIO Digital 2021. Results from the survey... » read more
ADELAIDE, AUS, May 27, 2021 – (ACN Newswire via SEAPRWire.com) – The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient Avance Clinical shared results of a recent industry survey conducted by the company that found data quality to be the most important criteria for selecting a CRO for... » read more
ADELAIDE, AUS, May 21, 2021 – (ACN Newswire via SEAPRWire.com) – Agilex Biolabs, Australia’s largest and most technologically advanced specialist bioanalytical laboratory for clinical trials is partnering with Endpoints News to share the latest on deconvoluting inflammation and immunology for clinical trials, in a webinar hosted by Endpoints News Editor Arsalan Arif. Agilex Biolabs’ Director,... » read more
ADELAIDE, AUS, May 7, 2021 – (ACN Newswire via SEAPRWire.com) – The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner, Avance Clinical, has expanded its gene technology clinical trial services to meet the increasing global demand predicted to reach $17.4 billion by 2023. Avance Clinical is accredited as... » read more
ADELAIDE, AUS, Apr 30, 2021 – (ACN Newswire via SEAPRWire.com) – Agilex Biolabs, Australia’s largest and most technologically advanced specialist bioanalytical laboratory for clinical trials, today congratulated client Bionomics Limited (Bionomics) on its positive pharmacokinetic (PK) results from a 7-day dosing study in healthy volunteers using the newly developed solid dose oral tablet formulation of... » read more
ADELAIDE, AU, Apr 22, 2021 – (ACN Newswire via SEAPRWire.com) – The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner Avance Clinical has been invited to present on the future of decentralized clinical trials at the Oracle Health Sciences Connect conference. Title: Decentralized Trials – No Going BackLink:... » read more
TOKYO, Apr 20, 2021 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. and Biogen Inc. today announced the publication of an article, A Randomized, Double-Blind Phase 2b Proof of Concept Clinical Trial in Early Alzheimer’s Disease with Lecanemab, an Anti-Abeta Protofibril Antibody, in the peer-reviewed journal Alzheimer’s Research and Therapy. The manuscript describes results... » read more
HONG KONG, Mar 24, 2021 – (ACN Newswire via SEAPRWire.com) – TOT BIOPHARM International Company Limited (“TOT BIOPHARM” or the “Company”; stock code: 1875.HK), a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative oncology drugs and therapies, announced today its audited annual results for the year ended 31 December 2020. Milestones of 2020 Annual... » read more
TOKYO, Mar 18, 2021 – (JCN Newswire via SEAPRWire.com) – Fujitsu today announced it has concluded a comprehensive collaborative research agreement with National Cancer Center Japan. The joint research will center on exploring ways that real-world data(1), including medical information from electronic records, can be leveraged to contribute to the development of new drugs, clinical... » read more
SINGAPORE – She is not just an infectious diseases doctor, but also the leader of one of the latest clinical trials of a Covid-19 antibody to treat patients with the virus. Dr Shirin Kalimuddin, a consultant with the Department of Infectious Diseases at Singapore General Hospital, is the principal investigator of a clinical trial of... » read more
ADELAIDE, AU, Feb 26, 2021 – (ACN Newswire) – The leading Australian CRO for biotechs, and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner, Avance Clinical continues to celebrate their strategic partnership with Medidata, and the accreditation of seven Medidata inhouse experts. The two organizations have been working together to deliver world-class clinical research... » read more
Reigning Singapore Gold Cup winner Big Hearted may have finished only sixth in his trial at Kranji on Thursday morning, but champion trainer Michael Clements was still pleased. After all, it was his charge’s first trial since capturing the 2,000m premier classic last November. Also, the trial winner, newcomer Sun Ops, clocked a swift 58.82sec... » read more
TOKYO, Feb 2, 2021 – (JCN Newswire) – O2 (Telefonica UK) and NEC Corporation (TSE: 6701) have announced a successful Open RAN trial on O2’s network with NEC and its ecosystem of partners that includes virtualized RAN software from Altiostar and hardware from GigaTera Communications and Supermicro among others. NEC helped to define a customized... » read more
HONG KONG, Jan 28, 2021 – (ACN Newswire) – China Biotech Services Holdings Limited (“CH BIOTECH SER” or “Company”, stock code: 8037.HK) non-wholly-owned subsidiary Shanghai Longyao Biotechnology Co., Ltd. ( “Shanghai Longyao”) received an approval letter from the National Medical Products Administration for a clinical trial of the Company’s LY007 Cellular Injection on January 21,... » read more
HONG KONG, Jan 18, 2021 – (ACN Newswire) – SinoMab BioScience Limited (“SinoMab” or the “Company”, stock code: 3681.HK), a Hong Kong-based biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological diseases, is pleased to announce that the first healthy subject was successfully dosed in the Phase... » read more
SINGAPORE – Residents of Block 202 Clementi Avenue 6 will soon be able to receive notification on their mobile phones when mail has arrived, negating the need to periodically check their letterbox. For the next year in fact, they will not need to check the letterbox at all, as mail will instead be collected from... » read more